Title: First Analysis of HOVON-65/GMMG-HD4 Randomized Phase III Trial Comparing Bortezomib, Adriamycine, Dexamethasone (PAD) Vs VAD as Induction Treatment Prior to High Dose Melphalan (HDM) in Patients with Newly Diagnosed Multiple Myeloma (MM)
Authors: Sonneveld, P
van der Holt, B
Schmidt-Wolf, I. G. H
Bertsch, U
el Jarari, L
Salwendcr, Hans-Juergen
Zweegman, S
Vellenga, E
Schubert, J
Blau, I. W
Jie, G. S. K
Beverloo, B
Jauch, A
Hose, D
Schaafsma, R
Kersten, M. J
Delforge, Michel
de Weerdt, O
van der Griend, R
Wijermans, R. W
Martin, Hans
van der Velde, H
Lokhorst, Henk M
Goldschimidt, H #
Issue Date: Nov-2008
Publisher: Amer soc hematology
Host Document: Blood vol:112 issue:11 pages:243-244
Conference: ASH edition:50 location:San Francisco date:6-9 December 2008
ISSN: 0006-4971
Publication status: published
KU Leuven publication type: IMa
Appears in Collections:Hematology Section (-)
# (joint) last author

Files in This Item:

There are no files associated with this item.


All items in Lirias are protected by copyright, with all rights reserved.